The Phase 1 trial will determine if the vaccine is safe for human use. It will also determine the proper dosage level and test for possible side effects, Ambrose said. Studies have shown the vaccine works in primates both to prevent infection when given before exposure and to increase survival chances when given quickly after exposure. Canada’s chief public health officer said results from the human trial are expected by December, and if successful, the next stage would be to test it in a larger human sample, including those directly handling Ebola cases in West Africa.“The health care workers on the ground are the most likely target to do the next step,” which could begin by the end of the year or early 2015, Dr. Gregory Taylor said in a news conference in Toronto. montrealgazette/health/Ebola+vaccine+tested+patients+isolated+hospitals+Edmonton+Ontario/10286668/story.html
Posted on: Mon, 17 Nov 2014 23:41:11 +0000
Trending Topics
Recently Viewed Topics
© 2015